BRCA1 and BRCA2 genes and hereditary breast cancers
28 Jun 2017
BRCA1 and BRCA2 genes and hereditary breast cancers
Stage 4 breast cancer surgery
The Umberto Veronesi Milan Breast Cancer Conference
4 years of RESONATE data for CLL patients treated with ibrutinib
Helping women with metastatic breast cancer get the information and support they need
Latest in relapsed and refractory multiple myeloma
Front-line combinations in multiple myeloma: Highlights from EHA 2017
Latest maintenance strategies in multiple myeloma
Lenalidomide with CD19 antibodies in L-MIND
The Myeloma XI trial - lenalidomide or thalidomide in triplet
Denosumab or zoledronic acid for bone disease in multiple myeloma
Hemcare - multiple myeloma learning programme